Literature DB >> 8815955

The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice.

E Del Pozo1, M Barrios, J M Baeyens.   

Abstract

The effect of the non-competitive NMDA receptor antagonist dizocilpine (MK-801) on conditioned place preference induced by morphine was studied in mice. As expected, morphine (1-8 mg/kg, i.p.) elicited a significant preference for the drug-paired compartment. Pretreatment of mice with (+)-dizocilpine (0.1 and 0.2 mg/kg, i.p.), the more active dizocilpine enantiomer, dose-dependently reversed the conditioned place preference produced by morphine (4 mg/kg, i.p.), whereas (-)-dizocilpine (0.2 mg/kg, i.p.) did not modify morphine-induced effects. In contrast, both enantiomers of dizocilpine (at a dose of 0.2 mg/kg, i.p.) elicited a conditioned place preference. These data suggest that (1) NMDA receptors play a role in morphine-induced place preference, and (2) dizocilpine-reinforcing properties in the place preference paradigm do not seem to be dependent on NMDA receptor blockade.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8815955     DOI: 10.1007/bf02247330

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

Review 1.  Receptor subtypes in opioid and stimulant reward.

Authors:  D W Self; L Stein
Journal:  Pharmacol Toxicol       Date:  1992-02

2.  The conditioned place preference is affected by two independent reinforcement processes.

Authors:  N M White; G D Carr
Journal:  Pharmacol Biochem Behav       Date:  1985-07       Impact factor: 3.533

3.  Repeated testing attenuates conditioned place preference with cocaine.

Authors:  M T Bardo; J L Neisewander; J S Miller
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  MK-801 prevents the development of behavioral sensitization during repeated morphine administration.

Authors:  M Jeziorski; F J White; M E Wolf
Journal:  Synapse       Date:  1994-02       Impact factor: 2.562

5.  Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists.

Authors:  K A Trujillo; H Akil
Journal:  Brain Res       Date:  1994-01-07       Impact factor: 3.252

6.  In vivo labelling of the NMDA receptor channel complex by [3H]MK-801.

Authors:  G W Price; R G Ahier; D N Middlemiss; L Singh; M D Tricklebank; E H Wong
Journal:  Eur J Pharmacol       Date:  1988-12-13       Impact factor: 4.432

7.  Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine.

Authors:  A Bespalov; M Dumpis; L Piotrovsky; E Zvartau
Journal:  Eur J Pharmacol       Date:  1994-11-03       Impact factor: 4.432

8.  Blockade of morphine-induced analgesia and tolerance in mice by MK-801.

Authors:  K Lutfy; D E Hurlbut; E Weber
Journal:  Brain Res       Date:  1993-07-09       Impact factor: 3.252

9.  The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat.

Authors:  S Ben-Eliyahu; P Marek; A L Vaccarino; J S Mogil; W F Sternberg; J C Liebeskind
Journal:  Brain Res       Date:  1992-03-20       Impact factor: 3.252

10.  Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats.

Authors:  W Löscher; R Annies; D Hönack
Journal:  Eur J Pharmacol       Date:  1993-10-05       Impact factor: 4.432

View more
  8 in total

1.  Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.

Authors:  Yoichi Kawasaki; Chunyu Jin; Katsuya Suemaru; Hiromu Kawasaki; Kazuhiko Shibata; Tominari Choshi; Satoshi Hibino; Yutaka Gomita; Hiroaki Araki
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

2.  Context-Specific Tolerance and Pharmacological Changes in the Infralimbic Cortex-Nucleus Accumbens Shell Pathway Evoked by Ketamine.

Authors:  Gleice Kelli Silva-Cardoso; Manoel Jorge Nobre
Journal:  Neurochem Res       Date:  2021-03-30       Impact factor: 3.996

3.  Glutamate transporter type 3 participates in maintaining morphine-induced conditioned place preference.

Authors:  Li Wan; Jiangjiang Bi; Jun Li; Zhiyi Zuo
Journal:  Neuroscience       Date:  2017-01-01       Impact factor: 3.590

4.  Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females.

Authors:  Cindee F Robles; Marissa Z McMackin; Katharine L Campi; Ian E Doig; Elizabeth Y Takahashi; Michael C Pride; Brian C Trainor
Journal:  Behav Brain Res       Date:  2014-01-18       Impact factor: 3.332

Review 5.  Modeling anxiety using adult zebrafish: a conceptual review.

Authors:  Adam Stewart; Siddharth Gaikwad; Evan Kyzar; Jeremy Green; Andrew Roth; Allan V Kalueff
Journal:  Neuropharmacology       Date:  2011-08-09       Impact factor: 5.250

6.  Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens.

Authors:  Eagle Y-K Huang; Te-Chen Liu; Pao-Luh Tao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-15       Impact factor: 3.000

7.  A Nonrewarding NMDA Receptor Antagonist Impairs the Acquisition, Consolidation, and Expression of Morphine Conditioned Place Preference in Mice.

Authors:  Lediane Tomazi; Carlos Fernando Mello; Ana Paula Schöffer; Bruna Amanda Girardi; Pâmella Karina Santana Frühauf; Maribel Antonello Rubin
Journal:  Mol Neurobiol       Date:  2016-01-14       Impact factor: 5.590

8.  Attenuation by dextromethorphan on the higher liability to morphine-induced reward, caused by prenatal exposure of morphine in rat offspring.

Authors:  Ling-Yi Wu; Jain-Fang Chen; Pao-Luh Tao; Eagle Yi-Kung Huang
Journal:  J Biomed Sci       Date:  2009-11-25       Impact factor: 8.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.